![David Jorden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Jorden
Directeur Général chez
NUO THERAPEUTICS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Mr. David E.
Jorden, CFA MBA, is a Chief Executive Officer & Director at Nanospectra Biosciences, Inc. and a CEO, CFO, Secretary & Director at Nuo Therapeutics, Inc. He is on the Board of Directors at Nanospectra Biosciences, Inc. and Nuo Therapeutics, Inc. Mr. Jorden was previously employed as a Chief Financial Officer by PLx Pharma, Inc., a Vice President by Morgan Stanley, a Chief Financial Officer & Vice President by Genometrix, Inc., a Principal by Fayez Sarofim & Co. LLC, and a Chief Financial Officer & Director by PLx Pharma, Inc. /Old/.
He also served on the board at Opexa Therapeutics, Inc. He received his undergraduate degree from The University of Texas at Austin and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUO THERAPEUTICS INC 4,31% | 05/06/2026 | 2 085 000 ( 4,31% ) | 2 M $ | 31/05/2026 |
Postes actifs de David Jorden
| Sociétés | Poste | Début |
|---|---|---|
| NUO THERAPEUTICS, INC. | Directeur Général | 08/01/2016 |
Nanospectra Biosciences, Inc.
 Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic products | Directeur Général | 01/06/2013 |
Anciens postes connus de David Jorden
| Sociétés | Poste | Fin |
|---|---|---|
| PLX PHARMA WINDDOWN CORP. | Directeur Financier/CFO | 01/07/2017 |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Directeur Financier/CFO | 02/04/2013 |
| MORGAN STANLEY | Corporate Officer/Principal | - |
Genometrix, Inc.
 Genometrix, Inc. Miscellaneous Commercial ServicesCommercial Services Performs commercial physical and biological research | Directeur Financier/CFO | 01/09/2002 |
Fayez Sarofim & Co. LLC
 Fayez Sarofim & Co. LLC Investment ManagersFinance FSC is a long-term investor which seeks to generate sustainable earnings growth by dominantly investing in large-cap companies. The firm employs a predominantly bottom-up investment decision-making process managed by the Investment Committee. The committee formulates a macroeconomic and capital market outlook and evaluates the attractiveness of the various economic sectors and industries. | Corporate Officer/Principal | - |
Formation de David Jorden
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Morgan Stanley
 Morgan Stanley Investment ManagersFinance Provides wealth and asset management, trading & investment banking services | Finance |
Fayez Sarofim & Co. LLC
Fayez Sarofim & Co. LLC Investment ManagersFinance FSC is a long-term investor which seeks to generate sustainable earnings growth by dominantly investing in large-cap companies. The firm employs a predominantly bottom-up investment decision-making process managed by the Investment Committee. The committee formulates a macroeconomic and capital market outlook and evaluates the attractiveness of the various economic sectors and industries. | Finance |
Nuo Therapeutics, Inc.
 Nuo Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops drugs for the treatment of chronic wounds | Health Technology |
Genometrix, Inc.
Genometrix, Inc. Miscellaneous Commercial ServicesCommercial Services Performs commercial physical and biological research | Commercial Services |
PLx Pharma, Inc. /Old/
 PLx Pharma, Inc. /Old/ Pharmaceuticals: OtherHealth Technology Develops formulations of non steroidal anti-inflammatory drugs | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic products | Health Technology |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PLx Pharma, Inc.
 PLx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops liquid-filled aspirin capsules for pain management | Health Technology |
